T. Rowe Price Capital Appreciation Fund (PRWCX)
Ticker Symbol:
PRWCX
Fund Status:
Closed to new Retail investors  /  Open to subsequent Retail investments
Closed to new Retail Investors as of June 30, 2014 at 4pm EST
Fund Composition
Asset Allocation
as of 03/31/2016
Domestic Stock 57.2%
Domestic Bond 18.7%
Cash 16.7%
Foreign Bonds 4.3%
Foreign Stock 1.6%
Convertibles 1.3%
Preferreds 0.9%
Options -0.3%
Volatility and Other Measures
as of 03/31/2016
Beta 0.63
0.94
Standard Deviation 7.33
Price/Earnings Ratio (Domestic) 18.2
Earnings Growth Rate (Domestic) 11.1
Turnover Rate 14.7
Median Market
Capitalization
$39,629.09 Million
Sector Diversification
as of 03/31/2016
% of Total Net Assets
Health Care 16.0%
Financials 12.6%
Industrials & Business Services 9.4%
Information Technology 9.0%
Consumer Discretionary 6.3%
Consumer Staples 3.5%
Utilities 1.8%
Energy 0.8%
Telecommunication Services 0.6%
10 Largest Holdings
Represents 24.88 % of Total Net Assets
View Holdings as of:
Abbott Laboratories
AutoZone
Bank of New York Mellon
Becton, Dickinson & Company
Danaher
Marsh & McLennan
Microsoft
PG&E
Thermo Fisher Scientific
Willis Group Holdings
As of 03/31/2016 the Capital Appreciation Fund had a total of 255 holdings.
See Glossary for additional details on all data elements.